Proteomic analysis of anaplasma phagocytophilum during infection of human myeloid cells identifies a protein that is pronouncedly upregulated on the infectious dense-cored cell

Infection and Immunity

Volumn 79, Issue 11, 2011, Pages 4696-4707

  Troese, Matthew J ^a   Kahlon, Amandeep ^a   Ragland, Stephanie A ^a   Ottens, Andrew K ^a   Ojogun, Nore ^a   Nelson, Kristina T ^b   Walker, Naomi J ^c   Borjesson, Dori L ^c   Carlyon, Jason A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; RNA;

ANAPLASMA PHAGOCYTOPHILUM; ARTICLE; BACTERIAL CELL; BONE MARROW CELL; CELL STRAIN HL 60; CONTROLLED STUDY; DENSE CORED CELL; HUMAN; HUMAN CELL; HUMAN GRANULOCYTIC ANAPLASMOSIS; IMMUNOELECTRON MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; UPREGULATION;

AMINO ACID SEQUENCE; ANAPLASMA PHAGOCYTOPHILUM; BACTERIAL PROTEINS; CENTRIFUGATION, DENSITY GRADIENT; CHROMATOGRAPHY, LIQUID; EHRLICHIA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HL-60 CELLS; HUMANS; MOLECULAR SEQUENCE ANNOTATION; MYELOID CELLS; PROTEOMICS; SPECIES SPECIFICITY; TANDEM MASS SPECTROMETRY; UP-REGULATION;

EID: 80855140062     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05658-11     Document Type: Article

References (62)

1. Abdelrahman, Y. M., and R. J. Belland. 2005. The chlamydial developmental cycle. FEMS Microbiol. Rev. 29:949-959.
2. Barbet, A. F., et al. 2003. Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilum. Infect. Immun. 71:1706-1718.
3. Borjesson, D. L., et al. 2005. Insights into pathogen immune evasion mechanisms: Anaplasma phagocytophilum fails to induce an apoptosis differentiation program in human neutrophils. J. Immunol. 174:6364-6372.
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
5. Carlyon, J. A. 2005. Laboratory maintenance of Anaplasma phagocytophilum, p. 3A.2.1-3A.2.30. In R. Coico, T. F. Kowalik, J. M. Quarles, B. Stevenson, and R. Taylor (ed.), Current protocols in microbiology. J. Wiley and Sons, Hoboken, NJ.
6. Carlyon, J. A., W. T. Chan, J. Galan, D. Roos, and E. Fikrig. 2002. Repression of rac2 mRNA expression by Anaplasma phagocytophila is essential to the inhibition of superoxide production and bacterial proliferation. J. Immunol. 169:7009-7018.
7. Caturegli, P., et al. 2000. ankA: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats. Infect. Immun. 68:5277-5283.
8. Chen, S. M., J. S. Dumler, H. M. Feng, and D. H. Walker. 1994. Identification of the antigenic constituents of Ehrlichia chaffeensis. Am. J. Trop. Med. Hyg. 50:52-58.
9. Cheng, Z., Y. Kumagai, M. Lin, C. Zhang, and Y. Rikihisa. 2006. Intraleukocyte expression of two-component systems in Ehrlichia chaffeensis and Anaplasma phagocytophilum and effects of the histidine kinase inhibitor closantel. Cell. Microbiol. 8:1241-1252.
10. Felsheim, R. F., et al. 2006. Transformation of Anaplasma phagocytophilum. BMC Biotechnol. 6:42.
11. Garcia-Garcia, J. C., N. C. Barat, S. J. Trembley, and J. S. Dumler. 2009. Epigenetic silencing of host cell defense genes enhances intracellular survival of the rickettsial pathogen Anaplasma phagocytophilum. PLoS Pathog. 5:e1000488.
12. Garcia-Garcia, J. C., K. E. Rennoll-Bankert, S. Pelly, A. M. Milstone, and J. S. Dumler. 2009. Silencing of host cell CYBB gene expression by the nuclear effector AnkA of the intracellular pathogen Anaplasma phagocytophilum. Infect. Immun. 77:2385-2391.
13. Geromanos, S. J., et al. 2009. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependent LC-MS/MS. Proteomics 9:1683-1695.
14. Goodman, J. L., et al. 1996. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 334:209-215.
15. Granick, J. L., D. V. Reneer, J. A. Carlyon, and D. L. Borjesson. 2008. Anaplasma phagocytophilum infects cells of the megakaryocytic lineage through sialylated ligands but fails to alter platelet production. J. Med. Microbiol. 57:416-423.
16. Grieco, F., J. M. Hay, and R. Hull. 1992. An improved procedure for the purification of protein fused with glutathione S-transferase. Biotechniques 13:856-858.
17. Heimer, R., A. Van Andel, G. P. Wormser, and M. L. Wilson. 1997. Propagation of granulocytic Ehrlichia spp. from human and equine sources in HL-60 cells induced to differentiate into functional granulocytes. J. Clin. Microbiol. 35:923-927.
18. Herron, M. J., M. E. Ericson, T. J. Kurtti, and U. G. Munderloh. 2005. The interactions of Anaplasma phagocytophilum, endothelial cells, and human neutrophils. Ann. N. Y. Acad. Sci. 1063:374-382.
19. Herron, M. J., et al. 2000. Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1. Science 288: 1653-1656.
20. Hotopp, J. C., et al. 2006. Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet. 2:e21.
21. Huang, B., et al. 2010. The Anaplasma phagocytophilum-occupied vacuole selectively recruits Rab-GTPases that are predominantly associated with recycling endosomes. Cell. Microbiol. 12:1292-1307.
22. Huang, B., et al. 2010. Anaplasma phagocytophilum APH_0032 is expressed late during infection and localizes to the pathogen-occupied vacuolar membrane. Microb. Pathog. 49:273-284.
23. Huang, B., et al. 2010. Anaplasma phagocytophilum APH_1387 is expressed throughout bacterial intracellular development and localizes to the pathogen-occupied vacuolar membrane. Infect. Immun. 78:1864-1873.
24. Huang, H., X. Wang, T. Kikuchi, Y. Kumagai, and Y. Rikihisa. 2007. Porin activity of Anaplasma phagocytophilum outer membrane fraction and purified P44. J. Bacteriol. 189:1998-2006.
25. IJdo, J. W., and A. C. Mueller. 2004. Neutrophil NADPH oxidase is reduced at the Anaplasma phagocytophilum phagosome. Infect. Immun. 72:5392-5401.
26. IJdo, J. W., C. Wu, L. A. Magnarelli, and E. Fikrig. 1999. Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HGE-44-based enzymelinked immunosorbent assay. J. Clin. Microbiol. 37:3540-3544.
27. IJdo, J. W., C. Wu, S. R. Telford, III, and E. Fikrig. 2002. Differential expression of the p44 gene family in the agent of human granulocytic ehrlichiosis. Infect. Immun. 70:5295-5298.
28. Jauron, S. D., et al. 2001. Host cell-specific expression of a p44 epitope by the human granulocytic ehrlichiosis agent. J. Infect. Dis. 184:1445-1450.
29. Kumagai, Y., Z. Cheng, M. Lin, and Y. Rikihisa. 2006. Biochemical activities of three pairs of Ehrlichia chaffeensis two-component regulatory system proteins involved in inhibition of lysosomal fusion. Infect. Immun. 74:5014-5022.
30. Lai, T. H., Y. Kumagai, M. Hyodo, Y. Hayakawa, and Y. Rikihisa. 2009. The Anaplasma phagocytophilum PleC histidine kinase and PleD diguanylate cyclase two-component system and role of cyclic di-GMP in host cell infection. J. Bacteriol. 191:693-700.
31. Li, G. Z., et al. 2009. Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics 9:1696-1719.
32. Lin, M., T. Kikuchi, H. M. Brewer, A. D. Norbeck, and Y. Rikihisa. 2011. Gloabal proteomic analysis of two tick-borne emerging zoonotic agents: Anaplasma phagocytophilum and Ehrlichis chaffeensis. Front Microbiol. 2:article 24. doi:10.3389/fmicb.2011.00024.
33. Lin, Q., and Y. Rikihisa. 2005. Establishment of cloned Anaplasma phagocytophilum and analysis of p44 gene conversion within an infected horse and infected SCID mice. Infect. Immun. 73:5106-5114.
34. Lin, Q., et al. 2002. Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J. Clin. Microbiol. 40:2981-2988.
35. -ΔΔCT method. Methods 25:402-408.
36. Lohr, C. V., et al. 2002. Expression of Anaplasma marginale major surface protein 2 operon-associated proteins during mammalian and arthropod infection. Infect. Immun. 70:6005-6012.
37. Munderloh, U. G., et al. 1999. Invasion and intracellular development of the human granulocytic ehrlichiosis agent in tick cell culture. J. Clin. Microbiol. 37:2518-2524.
38. Munderloh, U. G., et al. 2004. Infection of endothelial cells with Anaplasma marginale and A. phagocytophilum. Vet. Microbiol. 101:53-64.
39. Munderloh, U. G., et al. 1996. Isolation of the equine granulocytic ehrlichiosis agent, Ehrlichia equi, in tick cell culture. J. Clin. Microbiol. 34:664-670.
40. Nelson, C. M., et al. 2008. Whole genome transcription profiling of Anaplasma phagocytophilum in human and tick host cells by tiling array analysis. BMC Genomics 9:364.
41. Niu, H., V. Kozjak-Pavlovic, T. Rudel, and Y. Rikihisa. 2010. Anaplasma phagocytophilum Ats-1 is imported into host cell mitochondria and interferes with apoptosis induction. PLoS Pathog. 6:e1000774.
42. Palmer, G. H., T. Bankhead, and S. A. Lukehart. 2009. 'Nothing is permanent but change'-antigenic variation in persistent bacterial pathogens. Cell. Microbiol. 11:1697-1705.
43. Park, J., K. S. Choi, and J. S. Dumler. 2003. Major surface protein 2 of Anaplasma phagocytophilum facilitates adherence to granulocytes. Infect. Immun. 71:4018-4025.
44. Popov, V. L., et al. 1998. Ultrastructural differentiation of the genogroups in the genus Ehrlichia. J. Med. Microbiol. 47:235-251.
45. Rikihisa, Y. 2010. Anaplasma phagocytophilum and Ehrlichia chaffeensis: subversive manipulators of host cells. Nat. Rev. Microbiol. 8:328-339.
46. Rikihisa, Y., et al. 1997. Ultrastructural and antigenic characterization of a granulocytic ehrlichiosis agent directly isolated and stably cultivated from a patient in New York state. J. Infect. Dis. 175:210-213.
47. Scorpio, D. G., K. Caspersen, H. Ogata, J. Park, and J. S. Dumler. 2004. Restricted changes in major surface protein-2 (msp2) transcription after prolonged in vitro passage of Anaplasma phagocytophilum. BMC Microbiol. 4:1.
48. Shkap, V., T. Molad, K. A. Brayton, W. C. Brown, and G. H. Palmer. 2002. Expression of major surface protein 2 variants with conserved T-cell epitopes in Anaplasma centrale vaccinates. Infect. Immun. 70:642-648.
49. Singu, V., H. Liu, C. Cheng, and R. R. Ganta. 2005. Ehrlichia chaffeensis expresses macrophage- and tick cell-specific 28-kilodalton outer membrane proteins. Infect. Immun. 73:79-87.
50. Singu, V., et al. 2006. Unique macrophage and tick cell-specific protein expression from the p28/p30-outer membrane protein multigene locus in Ehrlichia chaffeensis and Ehrlichia canis. Cell. Microbiol. 8:1475-1487.
51. Skipp, P., J. Robinson, C. D. O'Connor, and I. N. Clarke. 2005. Shotgun proteomic analysis of Chlamydia trachomatis. Proteomics 5:1558-1573.
52. Sukumaran, B., et al. 2011. Anaplasma phagocytophilum AptA modulates Erk1/2 signalling. Cell. Microbiol. 13:47-61.
53. Tao, H., et al. 2010. Purifying natively folded proteins from inclusion bodies using sarkosyl, Triton X-100, and CHAPS. Biotechniques 48:61-64.
54. Thomas, R. J., J. S. Dumler, and J. A. Carlyon. 2009. Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis. Expert Rev. Anti Infect. Ther. 7:709-722.
55. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
56. Troese, M. J., and J. A. Carlyon. 2009. Anaplasma phagocytophilum densecored organisms mediate cellular adherence through recognition of human P-selectin glycoprotein ligand 1. Infect. Immun. 77:4018-4027.
57. Troese, M. J., et al. 2009. Differential expression and glycosylation of Anaplasma phagocytophilum major surface protein 2 paralogs during cultivation in sialyl Lewis x-deficient host cells. Infect. Immun. 77:1746-1756.
58. Wakeel, A., X. Zhang, and J. W. McBride. 2010. Mass spectrometric analysis of Ehrlichia chaffeensis tandem repeat proteins reveals evidence of phosphorylation and absence of glycosylation. PLoS One 5:e9552.
59. Webster, P., J. W. IJdo, L. M. Chicoine, and E. Fikrig. 1998. The agent of Human Granulocytic Ehrlichiosis resides in an endosomal compartment. J. Clin. Invest. 101:1932-1941.
60. Yu, C. S., Y. C. Chen, C. H. Lu, and J. K. Hwang. 2006. Prediction of protein subcellular localization. Proteins 64:643-651.
61. Zhi, N., N. Ohashi, and Y. Rikihisa. 1999. Multiple p44 genes encoding major outer membrane proteins are expressed in the human granulocytic ehrlichiosis agent. J. Biol. Chem. 274:17828-17836.
62. Zhi, N., et al. 2002. Transcript heterogeneity of the p44 multigene family in a human granulocytic ehrlichiosis agent transmitted by ticks. Infect. Immun. 70:1175-1184.